MetLife Inc., US59156R1086

TD Cowen raises target for MetLife stock to USD 110.00

Published on 10/06/2026 at 17:14 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

MetLife reported USD 2.43 earnings per share versus USD 2.30 consensus in the second quarter. For MetLife stock this means USD 3.00 billion in repurchases.

3D-Render eines schlanken Bürohochhauses mit Brunnenanlage und Bäumen davor
Architektur-Render eines modernen Glasturms mit Platzanlage, konzeptionell zugehörig zu MetLife Inc., ISIN US59156R1086, Illustration mit AI erstellt.

MetLife Inc. (ISIN US59156R1086) received a USD 110.00 price target from TD Cowen, up from USD 105.00, in a note dated October 5, 2026. According to Markets Insider, analyst Andrew Kligerman kept a Buy rating after meetings with management.

Target moves above recent price

The new target is USD 5.00 above the previous target, a 4.76 percent increase calculated from USD 105.00. Using the USD 98.32 NYSE price at 11:13 a.m. ET on October 6, 2026, the target lies 11.88 percent above the share price.

MarketBeat reported that 12 analysts carried Buy ratings and that the average target stood at USD 104.69. That average is USD 6.37 above the same USD 98.32 market price, while the target range extended from USD 84.00 to USD 119.00.

Second-quarter earnings set the base

MetLife reported USD 2.43 earnings per share for the second quarter of 2026, above the USD 2.30 consensus estimate, according to MarketBeat. The comparison represents a USD 0.13 per-share difference against expectations.

The same report said earnings per share rose from USD 2.02 in the prior-year quarter, an increase of 20.30 percent. It also described revenue of USD 13.52 billion against a USD 19.67 billion consensus estimate, while year-over-year revenue growth was reported at 10.50 percent.

Repurchases add a capital signal

MetLife authorized a USD 3.00 billion share-repurchase program on August 5, 2026, covering up to 4.80 percent of outstanding shares, according to MarketBeat. The authorization gives management another route to return capital while analysts reassess the shares.

NYSE price and valuation context

MetLife stock was USD 98.32 on the NYSE at 11:13 a.m. ET on October 6, 2026, against a USD 96.88 prior close. The market capitalization was USD 63.3 billion, and the 52-week range was USD 67.33 to USD 100.93 on the same date.

MetLife stock facts

  • Company: MetLife, Inc.
  • ISIN: US59156R1086
  • Ticker: MET
  • Primary exchange: NYSE
  • Primary-exchange price: USD 98.32 as of October 6, 2026 at 11:13 a.m. ET
  • Market capitalization: USD 63.3 billion as of October 6, 2026
  • 52-week range: USD 67.33-USD 100.93 as of October 6, 2026
  • Sector / Industry: Financials / Insurance - Life

More news and analyses on MetLife stock

Disclaimer...

en | US59156R1086 | METLIFE INC. | boerse | 70243674 | bgmi